Madrid

Laboratory and R&D+i plant for the research and development of high value-added or complex medicines.

Size

10,179 m²

Formulation capabilities

IR (Immediate Release), DR (Delayed Release), film coated and multilayer tablets
Soft gelatin and hard gelatin capsules
Semi-solid gels, creams and ointments

Pilot plants

CIt has three pilot plants that are completely isolated and validated under GMPs:
- Solid forms 1: development of high-power solid dosage forms, mainly tablets (coated or not).
- Solid forms 2: development of high-power solid dosage forms, mainly tablets (coated or not, multilayer tablets, core in core tablets).
- Soft capsules area: development and manufacturing of soft gelatin capsules for high-power medicines.

Our standards of quality

Cinfa Olloki

Plant
Headquarters and main facilities

Cinfa Huarte

Plant and R&D+i Centre
R&D+i, quality control, manufacturing and packaging of solids, liquids and flavours

Orliman

Plant
Development and manufacturing of orthopaedic products

Cyndea Pharma

Plant
Development and manufacturing of steroid based medicines and cancer treatments